Macrophages tightly scale their core metabolism after being activated, but the precise regulation of the mitochondrial electron-transport chain (ETC) and its functional implications are currently unknown. Here we found that recognition of live bacteria by macrophages transiently decreased assembly of the ETC complex I (CI) and CI-containing super-complexes and switched the relative contributions of CI and CII to mitochondrial respiration. This was mediated by phagosomal NADPH oxidase and the reactive oxygen species (ROS)-dependent tyrosine kinase Fgr. It required Toll-like receptor signaling and the NLRP3 inflammasome, which were both connected to bacterial viability-specific immune responses. Inhibition of CII during infection with Escherichia coli normalized serum concentrations of interleukin 1b (IL-1b) and IL-10 to those in mice treated with dead bacteria and impaired control of bacteria. We have thus identified ETC adaptations as an early immunological-metabolic checkpoint that adjusts innate immune responses to bacterial infection. 
A r t i c l e s
Macrophages are phagocytic immune cells that reside in most tissues and thus constitute the first line of host defense against invading microorganisms 1 . They express a wide variety of innate immunological receptors, which allows them to precisely determine microbial features such as pathogenicity, invasiveness or viability to 'fine tune' their differentiation program 2, 3 . To meet their immunological functions, macrophages metabolize a variety of carbon substrates, including glucose, fatty acids, ketone bodies and amino acids. Adaptations of cellular metabolism thus seem to be critically associated with macrophage activation [4] [5] [6] [7] and might contribute to macrophage functional requirements [8] [9] [10] . The activation of macrophages by the Gram-negative bacterial cell-wall component lipopolysaccharide (LPS) via Toll-like receptor 4 (TLR4) induces profound metabolic reprogramming that culminates in enhanced glycolysis, while glutamine replenishes the tricarboxylic acid (TCA) cycle through glutaminolysis 5, 7 . In turn, both accumulation of the TCA intermediate succinate and induction of the glycolytic enzyme hexokinase-1 contribute to production of the pro-inflammatory cytokine interleukin 1β (IL-1β) by regulating transcription of the gene encoding pro-IL-1β 7 and activating the NLRP3 inflammasome 11 , respectively. Accumulation of TCA-cycle intermediates might also directly contribute to macrophage antimicrobial functions. For example, LPS-activated macrophages accumulate citrate 5 that can be metabolized to itaconic acid, which exerts direct antibacterial effects on various pathogens, including Salmonella enterica Typhimurium, Mycobacterium tuberculosis or Legionella pneumophila 12, 13 .
At the core of the metabolic pathways is the mitochondrion, a bioenergetic organelle that not only contributes to energy supply, biosynthesis or cellular redox maintenance but also serves as a signaling platform for various innate immunological signaling pathways 9, 10, 14 . Mitochondria balance their contribution to anabolism and catabolism in response to the availability of fuel and oxygen, as well as in response to extracellular signals, including danger signals and cytokines 8, 9 . All catabolic processes converge on the mitochondrial electrontransport chain (ETC) by supplying electrons in the form of the reductive equivalents NADH and FADH 2 . The ETC comprises two electron carriers (coenzyme Q and cytochrome c) and four respiratory complexes (CI-CIV); these complexes, except for CII, can dynamically assemble as larger molecular super-complexes (SCs) in the mitochondrial inner membrane 15, 16 . The dynamic assembly of respiratory complexes into SCs has been proposed to confer functional advantages to the cells by potentiating electron flux within the ETC, preventing the generation of ROS by sequestering reactive intermediates or stabilizing individual respiratory complexes 15 . Whether super-assembly 1 0 3 8 VOLUME 17 NUMBER 9 SEPTEMBER 2016 nature immunology A r t i c l e s of ETC respiratory complexes can contribute to immunological function remains to be determined. Nevertheless, several studies have highlighted the potential importance of ETC respiratory complexes in macrophage activation. Chemical inhibition of CI impairs production of the pro-inflammatory cytokine IL-1β while inducing secretion of the anti-inflammatory cytokine IL-10 in activated macrophages 17 . In contrast, genetic ablation of the CI subunit NDUFS4 promotes an inflammatory macrophage phenotype 18 , which suggests that CI activity dampens macrophage activation.
Here, we investigated whether ETC adaptations contributed to the metabolic switch that occurs in myeloid cells after they were activated via innate immune receptors 5, 7 and would therefore affect antimicrobial responses. We report that the recognition of viable Gram-negative bacteria through TLR-and NLRP3-dependent pathways transiently decreased the abundance of SCs within the macrophage mitochondria due to destabilization of CI. The resultant dampening of CI activity was accompanied by an increase in the activity of CII. The induction of CII activity was not observed after phagocytosis of dead bacteria but was restored via bacterial RNA, a viability-associated pathogen-associated molecular pattern that signals microbial life to the immune system 19 . Conversely, inhibition of CII during challenge with viable bacteria normalized the amount of IL-1β and IL-10 to that found after an encounter with dead bacteria. Our findings identify a critical role for the mitochondrial ETC in innate immune responses to bacterial infection and highlight potential therapeutic interest in manipulating the ETC.
RESULTS

Sensing of bacteria affects mitochondrial ETC architecture
To determine whether the activation of innate immune cells affects the mitochondrial respiratory chain, we first analyzed the ETC organization of CD1 mouse bone-marrow-derived macrophages (BMDMs) left unchallenged ('resting') or challenged for 1.5 h with viable Escherichia coli K12, strain DH5α (called simply 'E. coli' here). Unlike C57BL/6 mice, CD1 mice express the long isoform of SC-assembly factor I and consequently assemble CIV-containing SCs, which reflects the situation in human cells 20 . Two-dimensional gel analysis of mitochondria isolated from CD1 BMDMs revealed respiratory SCs containing CI plus dimerized CIII plus CIV (CI + CIII 2 + CIV), CI plus dimerized CIII (CI + CIII 2 ) or dimerized CIII plus CIV (CIII 2 + CIV) 20, 21 in both resting macrophages and stimulated macrophages ( Fig. 1a and  Supplementary Fig. 1a) . We then analyzed whole-BMDM lysates by Coomassie-blue-stained native PAGE (blue native (BN)-PAGE). We observed a lower abundance of CI and CI-containing SCs (CI + CIII 2 + CIV and CI + CIII 2 ) in CD1 BMDMs that had phagocytosed live E. coli than in untreated BMDMs (Fig. 1b) . The amount of various ETC subunits (at the level of protein) was unaffected by E. coli challenge, despite mild transcriptional variation of some ETC-subunit-encoding nuclear genes ( Supplementary Fig. 1b-f) ; this suggested that the changes in SC abundance were due to alterations in SC assembly rather than to changes in protein expression. BMDMs from C57BL/6 mice (called 'wild-type' mice here) also exhibited a transient reduction in the amount of CI-and CIII-containing SCs when incubated with E. coli (Fig. 1b-e and Supplementary Fig. 2a,b) . Therefore, the disassembly of SCs after detection of viable bacteria affected all CI-containing SCs. ETC alterations were also observed in mouse peritoneal macrophages incubated with E. coli ( Supplementary  Fig. 2c ) and were also evident after recognition of Salmonella enterica serovar Typhimurium SL1344 (S. enterica Typhimurium) by BMDMs ( Supplementary Fig. 2d-f) . Thus, our data indicated that the recognition of Gram-negative bacteria by macrophages induced modifications of the ETC architecture that were characterized by a decrease in the abundance of CI-associated structures.
Detection of bacteria modulates ETC-complex activity
Macrophages activated through innate immune receptors use glutamine rather than glucose or fatty acids as the carbon source for oxidative phosphorylation [4] [5] [6] [7] . This adaptation results in a shift in the proportion of NADH-FADH 2 electrons that feed the ETC 22 , which requires modulation of the proportions of the various SCs 20, 23 . Stimulation of BMDMs with E. coli or S. enterica Typhimurium transiently impaired the in-gel NADH dehydrogenase activity of CI within CI + CIII 2 + CIV and CI + CIII 2 SCs (Fig. 1b,d and Supplementary  Fig. 2f ), which indicated a lower abundance of CI within SCs. Assessment of the activity of CI and that of CI + CIII in mitochondria isolated from BMDMs, by quantitative spectrophotometry, also indicated diminished CI-mediated respiration in response to E. coli relative to that in the resting condition (Fig. 2a) . However, we found that the activity of CII and that of CII + CIII was increased and that the total activity of CIII and CIV remained unaltered in this context (Fig. 2a) . To determine whether the decreased CI activity 'translated' into a drop in energy production, we measured the mitochondrial ATP-production rate in permeabilized BMDMs in the presence of glutamate plus malate, which generates intramitochondrial NADH that feeds electrons to CI 20 . CI-dependent ATP production was lower in BMDMs incubated with E. coli than in resting cells (Fig. 2b) . Thus, macrophage responses to bacteria were characterized by diminished assembly of CI into SCs and decreased overall CI activity, consistent with an anti-inflammatory role for CI in macrophages 18 . In line with the effect of LPS on macrophages 4, 5, 7 , E. coli-stimulated BMDMs had much lower oxygen consumption on a glucose substrate than that of resting BMDMs, while they exerted a high glycolytic activity that increased their extracellular acidification rate (ECAR) and lactate production at 18 h after infection relative to that of resting BMDMs ( Supplementary Fig. 3a-c) . However, we found that the maximal respiration rate (MRR) was greater in E. coli-treated BMDMs at 2 h after challenge than in untreated cells ( Fig. 2c and Supplementary  Fig. 3d ). This created a situation in which the spare respiratory capacity (SRC) (Fig. 2d) , ECAR (Fig. 2e ) and lactate production (Fig. 2f) were increased simultaneously in BMDMs after recognition of E. coli. Together these data indicated that the detection of E. coli by macrophages decreased the activity of ETC CI and thereby modulated mitochondrial respiratory parameters.
Recognition of bacteria stimulates mitochondrial CII
The concomitant decrease in the activity of CI + CIII and the increased MRR of E. coli-stimulated macrophages on a glucose substrate seemed to be contradictory and suggested that an alternative electron source would compensate for the expected decrease in NADH (CI)-dependent electron flux. We investigated whether bacterial infection-driven alterations in the macrophage ETC and the resulting diminished CI activity would favor the use of electrons from FADH 2 -oxidizing enzymes, as shown before 15, 20, 24 . We found much more CII enzymatic activity in peritoneal macrophages (Fig. 3a) or human CD14 + CD16 − primary monocytes (Fig. 3b) challenged with E. coli and in BMDMs challenged with S. enterica Typhimurium (Fig. 3c) than in their untreated counterparts. In addition, BMDMs incubated with E. coli increased their CII-mediated ATP production rate compared with that of resting cells (Fig. 3d) . The enhanced activity of CII (Fig. 3e) and of CII + CIII (Fig. 3f) was transient. The use of glucose catabolism to increase the maximum respiration rate despite a decrease in CI function would necessitate the delivery of NADH npg A r t i c l e s electrons generated by glycolysis to the mitochondrial ETC without the utilization of CI. This can be achieved by shuttling of cytoplasmic NADH electrons to coenzyme Q by mitochondria-bound glycerol-3-phosphate dehydrogenase (mG3PDH) 25 . Similar to the activity of CII, the activity of mG3PDH (Fig. 3g,h ) and of mG3PDH + CIII (Fig. 3i) was greater in BMDMs challenged with E. coli than in cells in the resting condition. Nevertheless, the increased CII activity reached a maximum at 0.5-1.5 h after E. coli challenge (Fig. 3e) , whereas the induction of mG3PDH was maintained for a longer time (Fig. 3h) . Together these data indicated that the recognition of E. coli by macrophages induced a transient increase in the activity of mitochondrial FADH 2 -dependent enzymes that feed electrons to CIII.
Phagosomal NADPH oxidase triggers ETC adaptations
Mitochondrial ROS (mROS), which increase within a few hours after E. coli is sensed 26 , are inherent to ETC function, which makes them potential regulators of CII activity in E. coli-stimulated macrophages. We were unable to detect substantial enhancement of mROS production in BMDMs at 1. 5 h after E. coli challenge compared with mROS production in BMDMs left untreated or treated with the mROSinducer rotenone (Supplementary Fig. 4a,b) . However, we found that both the mROS-specific inhibitor mitoQ 27 and the broad antioxidant N-acetyl cysteine decreased CII enzymatic activity in untreated or E. coli-stimulated BMDMs (Fig. 4a) , which suggested that mROS were required for proper CII function in macrophages. We next investigated if an alternative source of ROS, phagosomal NADPH oxidase 28 , was a regulator of CII activity. In BMDMs, 15 min of challenge with E. coli strongly induced ROS production compared with such production in untreated cells (Supplementary Fig. 4c ). BMDMs deficient in the NADPH oxidase subunit gp91 phox (Cybb −/− ; called 'Gp91phox −/− ' here) did not produce ROS in response to E. coli, in contrast to the production of ROS by wild-type BMDMs (Supplementary Fig. 4d-e) ; this demonstrated that the NADPH oxidase mediated ROS production in this context. In contrast to wild-type cells, Gp91phox −/− BMDMs did not increase the enzymatic activity of CII in response to E. coli (Fig. 4b) . Consequently, the E. coli-mediated increase in SRC observed in wild-type BMDMs was absent in Gp91phox −/− BMDMs ( Fig. 4c and Supplementary Fig. 4f,g ), while the induction of ECAR was similar in wild-type and Gp91phox −/− cells (Fig. 4d) . The absence of gp91 phox also prevented the decrease in the abundance of SCs in mitochondria isolated from E. coli-stimulated BMDMs that was observed in wild-type cells (Fig. 4e,f) . Together these results indicated that phagosomal ROS were an early inducer of ETC adaptations in macrophages during the sensing of bacteria and acted together with mROS to complete those adaptations.
E. coli-mediated induction of CII activity requires Fgr CII activity adapts to fuel use through H 2 O 2 -mediated activation via phosphorylation of the CII subunit SDHA by the Src-family tyrosine kinase Fgr 29 , the partner kinase of the phosphatase PTPMT1 (ref. 30) . Fgr deficiency prevented the decrease in abundance of SCs induced by E. coli challenge in permeabilized wild-type BMDMs ( Supplementary  Fig. 5a -e) and in mitochondria isolated from wild-type BMDMs (Supplementary Fig. 5f-i mice did not show the decrease in CI activity or the increase in CII activity observed in wild-type BMDMs in response to E. coli ( Fig. 5a and Supplementary Fig. 5j ). Similarly, Fgr −/− BMDMs preserved their CI-dependent ATP production and did not enhance their CIImediated ATP production after detecting E. coli, in contrast to wild-type BMDMs (Fig. 5b) . As a consequence, Fgr −/− BMDMs challenged with E. coli did not show a higher MRR ( Supplementary  Fig. 5k ) or greater SRC (Fig. 5c ) than that of resting Fgr −/− BMDMs but did show an increase in ECAR ( Fig. 5d ) and lactate production ( Fig. 5e ) similar to that of wild-type BMDMs stimulated with E. coli. These results indicated that Fgr was an important regulator of macrophage ETC adaptations during bacterial infection.
Metabolic reprogramming toward glycolysis and the accumulation of succinate 7 , together with an increase in mROS production 26 , contributes to the antimicrobial functions of macrophages. In line with that, Fgr −/− BMDMs had more intracellular E. coli upon infection in vitro than that of wild-type BMDMs (Fig. 5f) , indicative of enhanced survival of the bacteria within Fgr −/− BMDMs. However, Fgr-deficient and wild-type mice had an equal number of colonyforming units (CFU) of E. coli in the spleen after intraperitoneal infection with this bacteria (Supplementary Fig. 5l,m) . In line with that, induction of the inflammatory-cytokine-encoding genes Il1b, Ifnb and Tnf in response to challenge with E. coli was similar in wildtype and Fgr −/− BMDMs (Supplementary Fig. 5n) , despite slightly Fig. 5o ). Together these results indicated that other kinases of the Src family might have compensated for the loss of Fgr in the expression of inflammatory cytokines 31 .
CII activity contributes to anti-microbial responses
Because Fgr has other targets beyond CII, we used the succinate dehydrogenase (SDH)-specific inhibitor 3-nitropropionic acid (NPA) 32 to block CII activity. At the concentrations tested, NPA did not affect the survival or phagocytic activity of wild-type BMDMs ( Supplementary Fig. 6a,b ) but strongly repressed CII activity in resting and E. coli-stimulated BMDMs relative to its activity in untreated BMDMs (Supplementary Fig. 6c ) without affecting bacterial SDH activity or growth ( Supplementary Fig. 6d,e) . Treatment of wild-type BMDMs with NPA did not prevent SC disassembly ( Supplementary  Fig. 6f ) or the drop in CI-mediated ATP production induced by E. coli challenge but efficiently prevented the increase in CII-mediated ATP production induced similarly (Supplementary Fig. 6g ), in contrast to results obtained for untreated BMDMs. NPA treatment also substantially diminished the MRR induced by E. coli ( Fig. 6a and Supplementary Fig. 6h ) and ablated the increase in SRC (Fig. 6b) without affecting induction of the ECAR (Fig. 6c and Supplementary  Fig. 6i ) or production of lactate (Supplementary Fig. 6j ) in wildtype BMDMs. Similar results were obtained with the CII competitive inhibitors dimethyl-malonate 33 and thenoyltrifluoroacetone ( Supplementary Fig. 6k-o) .
We next investigated whether CII activity contributed to antimicrobial function. Mice treated with NPA were more susceptible to infection with S. enterica Typhimurium than were mice treated with vehicle ( Fig. 6d) and had a greater splenic bacterial burden at 72 h after intra-peritoneal infection with viable E. coli than that of their counterparts treated with vehicle (Fig. 6e) , despite normal recruitment of inflammatory cells to the peritoneal cavity ( Supplementary  Fig. 7a) . The greater bacterial load in NPA-treated mice correlated with their lower serum concentrations of the pro-inflammatory cytokine IL-1β and higher concentrations of anti-inflammatory cytokine IL-10 than those of vehicle-treated mice, while their concentration of the cytokine TNF was not affected relative to that of vehicle-treated mice (Fig. 6f) . We also found a greater number of viable E.coli in NPA-treated BMDMs than in vehicle-treated BMDMs (Fig. 6g,h) , which indicated that inhibition of CII impaired macrophage bactericidal activity in vitro. In addition, NPA-treated BMDMs 
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had lower E. coli-induced expression of IL-1β protein and Il1b and Ifnb mRNA than that of their untreated counterparts but had TNF expression similar to that of their untreated counterparts ( Supplementary  Fig. 7b,c) , consistent with the relative insensitivity of TNF production to macrophage-metabolic fluctuations and oxygen availability 7, 34 . Itaconic acid, which results from decarboxylation of the TCA-cycle intermediate cis-aconitate, has anti-bacterial properties 12 . We found that the TCA-cycle intermediate fumarate, which is produced by the oxidation of succinate by CII, strongly inhibited bacterial growth (Supplementary Fig. 7d ) and induced bacterial death, while succinate had negligible effects relative to those of PBS ( Supplementary  Fig. 7e,f) . To exclude the possibility that mere lowering of the pH accounted for the observed effects of fumarate on bacteria viability, we used ester forms of these TCA intermediates. Dimethyl fumarate impaired the growth of E. coli (Fig. 6i) and S. enterica Typhimurium in vitro (Fig. 6j) , but dimethyl succinate did not. These data identified CII as an important contributor to the macrophage mitochondrial respiratory functions needed for anti-microbial responses.
Microbial viability drives ETC adaptations
In contrast to viable E. coli, heat-killed E. coli did not affect the assembly of CI or the CI + CIII 2 SC in BMDMs ( Fig. 7a and Supplementary  Fig. 8a,b) . In contrast to viable E. coli, heat-killed E. coli did not impair the in-gel activity of CI within the CI + CIII 2 SC (Fig. 7a) and failed to increase mitochondrial MRR (Supplementary Fig. 8c) or SRC (Fig. 7b) in BMDMs. However, viable and heat-killed E. coli both efficiently induced ECAR (Fig. 7c) , lactate release ( Supplementary  Fig. 8d ) and mG3PDH activity (Supplementary Fig. 8e ) in BMDMs, probably reflective of the ability of LPS to trigger a glycolytic switch in macrophages 5, 7 . Unlike viable E. coli, heat-killed E. coli did not induce CII activity in BMDMs (Fig. 7d) , human CD14 + CD16 − monocytes (Fig. 7e) or peritoneal macrophages (Supplementary Fig. 8f) . Notably, live E. coli were more efficient than heat-killed E. coli at inducing phagosomal ROS production by wild-type BMDMs (Fig. 7f and Supplementary Fig. 8g) , which was required for the induction of CII and SRC in macrophages. These findings indicated that stimuli associated with viable bacteria triggered ETC adaptations in macrophages.
An association with bacterial viability has been suggested for several bacterial molecules 2, 35 , including bacterial RNA 19 . We found that CII activity in BMDMs was enhanced in response to RNA purified from E. coli and was unaffected when the RNA preparations were pre-treated with RNases ( Fig. 7g and Supplementary Fig. 8h ). The double-stranded RNA mimic polyinosinic:polycytidylic acid (poly(I:C)) and the single-stranded RNA mimic R848 (which trigger TLR3 and TLR7, respectively) also induced CII activity in BMDMs 
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A r t i c l e s (Fig. 7h) , whereas LPS (a TLR4 agonist) and the oligodeoxynucleotide CpG (a TLR9 agonist) did not ( Fig. 7h and Supplementary  Fig. 8i-j) . This was also evident in human CD14 + CD16 − monocytes (Fig. 7e) . In addition, treatment with poly(I:C) decreased CI-mediated ATP production and promoted CII-mediated ATP production in permeabilized BMDMs relative to that in resting cells (Fig. 7i) . These results indicated that recognition of microbial RNA controlled CII activity. Because bacterial RNA triggers viability-specific immune responses through the adaptor TRIF 19 , we evaluated the contribution of TLR adaptors to ETC changes induced by E. coli. In contrast to wild-type cells, BMDMs generated from mice deficient in TRIF (Ticam1 −/− ; called 'Trif −/− ' here) or the adaptor MyD88 (Myd88 −/− ) or both (Trif −/− Myd88 −/− ) did not undergo induction of CII activity when exposed to bacteria (Fig. 7j) . In contrast, the induction of CII activity after challenge with E. coli was unaffected in BMDMs deficient in STING or MAVS (Supplementary Fig. 8k) , two adaptors that use mitochondria to mediate the sensing of nucleic acids and poly(I:C) by cytosolic receptors 14 . In addition, both TRIF and MyD88 were required for the initiation of changes in ETC composition after E. coli was sensed (Fig. 7k,l and Supplementary Fig. 8l) . Thus, the adjustments to CII function in response to bacteria were probably regulated by phagosomal RNA-sensing TLRs rather than by cytosolic nucleic-acidsensing innate immunological receptors 2 . Viability-specific immune responses and sensing of bacterial RNA also involve the NLRP3 inflammasome 2, 19, 36 , the activation of which has been linked to mitochondria, phagosomal NADPH oxidase and ROS release 2, 14, 19, 36, 37 . Both the induction of CII (Fig. 7m) and the decrease in ETC superassembly ( Fig. 7n and Supplementary Fig. 8m ) were markedly impaired in E. coli-treated BMDMs deficient in NLRP3 (Nlrp3 −/− ) or in caspase-1 and casepase-11 (Casp1 −/− Casp11 −/− ) relative to that in E. coli-challenged wild-type cells, which would place CII activation at the center of viability-specific immune responses to bacteria. Consistent with that, treatment of E. coli-infected wild-type mice with the CII inhibitor dimethyl-malonate diminished the serum concentration of IL-1β and increased the serum concentration of IL-10 to their concentrations in mice treated with heat-killed E. coli without influencing serum concentration of the IL-6 (Fig. 8) . Together these npg A r t i c l e s data suggested that CII activity regulates cytokine production by macrophages during bacterial infection (Supplementary Fig. 8n ).
DISCUSSION
Our study has described a mechanism by which macrophages adjusted their metabolism in response to viable bacteria by coupling TLR engagement, the NLRP3 inflammasome and ROS signaling to the mitochondrial ETC. This metabolic adjustment in turn contributed to pathogen-specific immune responses. The ETC architecture was altered in response to the detection of viable bacteria because of a decrease in the abundance of assembled CI. Several explanations can account for this. CI is an unstable ETC multiprotein complex composed of 44 different protein subunits, the assembly of which is influenced by the oxidative environment within the ETC 15 and/or by previous assembly of other ETC components, including CIII 38 or cytochrome c oxidase 39 . A switch in the substrate that fuels the TCA cycle modifies the NADH/FADH 2 ratio, which can saturate the oxidation capacity of the coenzyme Q pool and thereby induce a reverse electron transfer toward CI. This in turn increases superoxides that oxidize specific CI proteins and thereby leads to disassembly of the complex 23 . After engagement of surface TLRs, ROS expression within the ETC is increased 26 and this constitutes a potential source of CI-destabilizing ROS. In addition, a modulation of the NADH/FADH 2 ratio that induces reverse electron transfer is likely to occur here because activation of innate immunological receptors diverts pyruvate from entering the mitochondria and limits fatty-acid oxidation, while glutaminolysis ensures replenishment of the TCA cycle 5, 40 .
Unless an as-yet-to-be-determined bacterial viability-specific metabolic-flux adaptation further modulates the NADH/FADH 2 ratio, CI destabilization should occur in response to both heat-killed bacteria and viable bacteria. However, we observed alterations in the ETC only in response to the latter. In addition, the inhibition of CII in macrophage challenged with viable E. coli did not impair the decrease in the abundance of CI and CI-containing SCs, nor did it prevent the decrease in CI-mediated ATP synthesis. Phagosomal ROS might also account for the oxidative destabilization of CI. Indeed, we found that gp91 phox -deficient macrophages had preserved ETC architecture in response to viable E. coli and that phagosomal ROS concentrations in wild-type macrophages were substantially lower in response to heat-killed E. coli than in response to live bacteria. However, gp91 phox deficiency also impaired the induction of CII activity and, as a consequence, might also prevent CI-destabilizing reverse electron transfer. Therefore, whether the changes in ETC architecture after challenge with viable bacteria were a consequence of the rapid increase in oxidative burst within the ETC due to innate immune signaling or resulted from a fuel switch remains to be determined. Nevertheless, our data indicated that recognition of E. coli induced a transient alteration in SCs in macrophages, which might make CIII available for electrons provided by FADH 2 -dependent enzymes and thereby allow mitochondria to re-oxidize cytoplasmic NADH without the use of CI, as shown in other models 15, 20 .
Whether metabolic reprogramming directly contributes to macrophage effector function remains unclear. Itaconate, a non-amino organic acid, can exert antimicrobial functions at a concentration of about 10 mM (refs. 12,13) . Consistent with that, we found that the CII enzymatic product fumarate prevented bacterial growth in vitro and decreased bacterial viability at a concentration of 10 mM, but its precursor succinate did not. At such concentrations, the pH is merely decreased and should therefore impair normal macrophage function. However, after macrophages encounter bacteria, mitochondria are juxtaposed to microbe-containing phagosomes 26, 41 . This is mediated by the formation of a complex between the TLR signaling adaptor TRAF6 and the mitochondrial CI-assembly factor ECSIT 26 , the interaction of which is regulated by the Mst1-Mst2-Rac signaling axis 41 . Such proximity between mitochondria and bacteria-containing phagosomes might permit the delivery of mROS or mitochondrial metabolites to contribute to the killing of bacteria 14 . Such model presents some advantages because it would allow those 'antimicrobial metabolites' to reach sufficient concentrations locally (i.e., within the phagosome) while sparing host cellular metabolism. Future work should provide additional insight into this issue.
The use of LPS to activate macrophages has generated a considerable amount of information on the metabolic pathways and reprogramming engaged during inflammation 8 . We found that challenge of macrophage with heat-killed bacteria recapitulated many aspects of LPS-mediated engagement of TLR4 on mitochondrial respiration, including induction of glycolytic flux (increased ECAR and lactate release) and decreased oxygen consumption in the mitochondria. However, we observed the induction of CII activity and destabilization of the ETC only in response to viable bacteria. Therefore, while the use of a single pathogen-associated molecular pattern certainly presents advantages, it offers only a partial view of the complexity of the innate immunological signals that might regulate metabolic adjustments after an encounter with a whole viable microorganism. This is not trivial, because macrophages tightly 'scale' their response to many features of bacteria, including viability-specific signals 2, 35 . Most notably, we found that the inhibition of CII during challenge of mice with viable bacteria increased the concentration of IL-10 and decreased the concentration of IL-1β in the serum to the concentrations observed when heat-killed bacteria were used. Thus, the establishment of a functional link among pattern-recognition receptors, ETC organization and subsequent inflammatory immune responses might offer substantial benefits for vaccine design and provide valuable new targets for pharmacological intervention both during infection and in metabolic inflammatory disorders.
METHODS
Methods and any associated references are available in the online version of the paper. npg cells incubated on ice for 10 min. Cold PBS (1 ml) was added and cells were centrifuged for 5 min at 10,000g. The pellet was suspended in 100 µl of AA buffer (500 mM 6-aminohexanoic acid, 50 mM immidazole, 1 mM EDTA, pH 7) and 10 µl of a 10% digitonin solution was added. Cells were centrifuged for 30 min at 18,000g. Supernatant was harvested and 10 µl of sample buffer (5% Blue G-250, 5% glycerol in AA Buffer) was added. Samples were stored at −80 °C until use. BN-PAGE was performed as described 47 . For two-dimensional gel analysis, 50-75 µg of mitochondria were digitoninpermeabilized with 4 µg digitonin per µg of protein and loaded on a BN polyacrylamide gel. Each individual band on the BN-PAGE was cut out and incubated for 1 h in buffer containing 1% SDS and 1% 2-mercaptoethanol. The buffer was replaced with a 1% SDS solution and incubation was continued for 30 min. BN-PAGE bands were loaded on an SDS polyacrylamide gel composed of a 10% acrylamide/Bis-acrylamide (AB) stacking gel and a 16% AB resolving gel. Electrophoresis was performed overnight at 12-15 mA, and proteins were transferred to a PVDF membrane using a Trans-Blot Semi-Dry Transfer Cell (Bio-Rad). For in-gel OXPHOS complex activity assays, CI was revealed by incubating the BN gel for 1-3 h in 0.1M Tris-HCl, pH 7.5, containing 1 mg/ml NBT and 0.14 mM NADH. For densitometry analysis, the ImageJ64 software was used. Band limits were determined using low-exposure images to efficiently distinguish the different bands. Background correction was applied for each analysis.
Oxidative-phosphorylation function and enzyme activities. CII activity was measured spectrophotometrically from the reduction of 2,6-diclorophenolindophenol (DCPIP) by tracking the absorbance at 600 nm over 3 min as described 48 with some modifications. 3 × 10 6 cells were suspended in 100 µl PBS on ice. Protein concentration was determined and the volume was adjusted to the lowest concentrated sample. Sample (20 µl) was suspended in 950 µl of buffer C1/C2 (25 mM potassium phosphate (K 2 HPO 4 ) pH = 7.2, 5 mM MgCl 2 , 3 mM KCN, 2.5 mg/ml BSA) supplemented with 100 mM succinate and 0.1% Triton X-100, and incubated 10 min at room temperature in a cuvette. After addition of 6 µl 5 mM DCPIP, 2 µl 1 mg/ml of antimycin A and 2 µl 1 mM rotenone, samples were incubated for 2 min. Then, 6 µl of 10 mM UQ 1 was added and absorbance was measured. CII activity was extrapolated using the following formula: [CII activity = ((rate/min)/19.1) / sample volume × 1000 × dilution factor], where 19.1 is the molar extinction coefficient at 30 °C (mM −1 cm −1 ). For CII + CIII, UQ 1 was replaced with 1 mM oxidized cytochrome c (Sigma). For SDH activity, UQ 1 was replaced with phenazine methosulfate (PMS). For mitochondrial glycerol 3-phosphate dehydrogenase (mG3PDH) activity, succinate was replaced with 1 M glycerol-3-phosphate. For OXPHOS enzymatic activities in isolated mitochondria, individual and combined complex activities of isolated mitochondria were measured spectrophotometrically as described 48 . The CII-, CII-plus-CIII-and mG3PDH-specific activities corresponding to 100% activity measured in permeabilized untreated BMDMs are 0.0165 ± 0.005 IU/mg protein (N = 25), 0.020 ± 0.008 IU/mg protein (N = 4) and 0.0180 ± 0.006 IU/mg protein (N = 18), respectively.
ATP synthesis assay. ATP synthesis was measured in permeabilized cells by kinetic luminescence assay 49 . Cells (2 × 10 6 ) were suspended in 160 µl of buffer A (150 mM KCl, 25 mM Tris-HCl, 2 mM EDTA, 0.1% BSA FA, 10 mM K-phosphate, 0.1 mM MgCl 2 , pH 7.4) at room temperature and 50 µg/ml digitonin was added. Samples were mixed gently for 1 min, and the reaction was stopped by addition of 1ml of buffer A. Cells were centrifuged at 3,000 r.p.m. for 2 min at room temperature, and pellets were suspended in 160 µl of buffer A and dispensed into the wells of a 96-well luminescence reading plate (Costar). Substrate cocktail (50 µl) and 20 µl of buffer B (0.5 M Tris-acetate, pH 7.75, 0.8 mM luciferine, 20 µg/ml luciferase) were added, and luminescence was measured over 1 min. Substrate cocktails were composed of 6 mM diadenosin pentaphosphate and 6 mM ADP supplemented with 1 M glutamate + 1 M malate for determination of CI activity or with 1 M succinate for CII activity. ATP production rate is presented as 'nmol of ATP/min/mg of protein.' All measurements were performed in triplicate.
Phagocytosis assay. Macrophages (3 × 10 5 ) were seeded in triplicate on an untreated 24-well plate (BD Biosciences). Cells were challenged with 6 × 10 6 3-µm Fluoresbrite microspheres (Polysciences) or 3 × 10 6 E. coli-GFP and centrifuged for 5 min at 400g. After 20 min incubation, cells were washed with PBS, harvested in PBS containing 5 mM EDTA, and analyzed by flow cytometry.
Cytokine enzyme-linked immunosorbent assay (ELISA). IL-1β, IL-10 and TNF-α ELISA kits were from BD Biosciences. Capture/detection antibodies for IL-6 were from BD Biosciences. Supernatants from BMDMs were collected at 24 h after stimulation. ELISA kits are used according to the manufacturer's instructions. Detection antibodies were biotinylated and labeled with streptavidin-conjugated horseradish peroxidase (HRP, from invitrogen) and visualized by incubation with 5,5′-tetramethylbenzidine solution (TMB, KPL). Color development was stopped with TMB-stop solution (KPL). Recombinant cytokines served as standards and were purchased from Peprotech. Absorbance at 450 nm was measured on a microplate reader (Benchmark Plus, Bio-Rad).
In vitro and in vivo infection and bactericidal activity experiments. For in vitro experiments, BMDMs were plated at 2 × 10 5 cells/well in triplicate on a 24-well plate in an antibiotic-free complete medium. BMDMs were infected with DH5α or SL1344 at a multiplicity of infection of 5 and centrifuged for 5 min at 400g. After 30 min incubation, cells were washed and complete medium supplemented with 50 µg/ml gentamycin was added. At the indicated time point after infection, cells were washed with PBS and 1 ml of PBS containing 1% Triton X-100 was added. Plates were incubated at room temperature for 15 min and serial dilutions (1/10, 1/100, 1/1,000) were plated on an LB-agar plate, which in the case of SL1344 contained 50 µg/ml streptomycin. Plates were incubated at 37 °C and bacterial colonies were counted. When needed, cells were pretreated with 3-nitropropionic acid (NPA) 30 min before infection; the inhibitor concentration was maintained throughout the experiment. For in vivo experiments, mice were injected intraperitoneally (i.p.) with 50 mg/kg NPA 1 h before infection. Injection of inhibitor was repeated every second day over the course of the experiment. For E. coli infection, mice were injected i.p. with 1 × 10 8 DH5α and sacrificed at 72 h after infection. Spleens were harvested and homogenized in 5 ml PBS, and serial dilutions were plated on LB-agar plates for colony counting. For peritoneal cell analysis, mice were injected i.p. with 1 × 10 8 DH5α. 12 h later, mice were sacrificed and peritoneal cells were collected in 8 ml ice-cold PBS. Each experiment included four to five mice per group and was repeated three times with similar results. No specific blinding or randomization strategy was used. No animal was excluded from analysis. 
